Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 517Prostatic Neoplasms 335Colorectal Neoplasms 273Neoplasms 268Multiple Myeloma 267Leukemia, Myeloid, Acute 224Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 197Melanoma 175Triple Negative Breast Neoplasms 173Pancreatic Neoplasms 171Recurrence 152Ovarian Neoplasms 152Lymphoma 141Glioblastoma 134Brain Neoplasms 133Sarcoma 130Carcinoma, Renal Cell 129Stomach Neoplasms 125Lymphoma, Large B-Cell, Diffuse 125Leukemia, Lymphocytic, Chronic, B-Cell 125Head and Neck Neoplasms 125Rectal Neoplasms 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Myelodysplastic Syndromes 103Uterine Cervical Neoplasms 100Urinary Bladder Neoplasms 100

Interventions

hetrombopag 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Therapy-induced Thrombocytopenia (CTIT) × 1 year × Clear all
NCT07334093 2026-01-12

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Sun Yat-sen University

Phase 2 Not yet recruiting
204 enrolled
Classical hematology

Cancer Therapy-induced Thrombocytopenia (CTIT)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡